We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+12.96%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$5.94B
AUM Growth
+$564M
Cap. Flow
-$17.2M
Cap. Flow %
-0.29%
Top 10 Hldgs %
20.14%
Holding
851
New
40
Increased
303
Reduced
396
Closed
33

Top Buys

Rank Stock Value
1
LVS icon
Las Vegas Sands
LVS
+$6.05M
2
MP icon
MP Materials
MP
+$5.29M
3
ROG icon
Rogers Corp
ROG
+$4.8M
4
FANG icon
Diamondback Energy
FANG
+$4.32M
5
QDEL icon
QuidelOrtho
QDEL
+$3.61M

Sector Composition

Rank Sector Weight
1 Technology 23.74%
2 Healthcare 11.93%
3 Financials 9.88%
4 Industrials 9.8%
5 Consumer Discretionary 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIA icon
51
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.5B
$27.8M 0.47%
73,740
-1,501
-2% -$525K
IJR icon
52
iShares Core S&P Small-Cap ETF
IJR
$110B
$27.7M 0.47%
256,001
-5,737
-2% -$553K
CP icon
53
Canadian Pacific Kansas City
CP
$77.5B
$27.4M 0.46%
347,010
+4,976
+1% +$364K
ADBE icon
54
Adobe
ADBE
$98.5B
$26.9M 0.45%
45,143
-1,169
-3% -$674K
TRMB icon
55
Trimble
TRMB
$13.3B
$26.3M 0.44%
495,047
-4,216
-0.8% -$201K
CVX icon
56
Chevron
CVX
$383B
$25.5M 0.43%
170,957
+18,945
+12% +$2.87M
HON icon
57
Honeywell
HON
$76.7B
$25.5M 0.43%
128,941
+10,614
+9% +$1.91M
RJF icon
58
Raymond James Financial
RJF
$33.6B
$25.2M 0.42%
226,342
-2,313
-1% -$238K
BX icon
59
Blackstone
BX
$102B
$25.1M 0.42%
192,054
+2,179
+1% +$236K
MKL icon
60
Markel Group
MKL
$23.4B
$25.1M 0.42%
17,656
+1,167
+7% +$1.66M
FDX icon
61
FedEx
FDX
$73B
$24.6M 0.41%
97,091
+1,029
+1% +$261K
MSGS icon
62
Madison Square Garden
MSGS
$9.75B
$24.1M 0.41%
132,762
+1,222
+0.9% +$212K
PEP icon
63
PepsiCo
PEP
$191B
$24M 0.4%
141,227
+4,561
+3% +$756K
LVS icon
64
Las Vegas Sands
LVS
$32.3B
$24M 0.4%
487,363
+128,084
+36% +$6.05M
ORCL icon
65
Oracle
ORCL
$367B
$23.3M 0.39%
221,266
+6,304
+3% +$688K
IONS icon
66
Ionis Pharmaceuticals
IONS
$8.85B
$23.2M 0.39%
458,979
-4,056
-0.9% -$194K
AMBA icon
67
Ambarella
AMBA
$3.25B
$23M 0.39%
375,187
-1,876
-0.5% -$102K
LASR icon
68
nLIGHT
LASR
$3.71B
$22.9M 0.38%
1,693,821
+258,199
+18% +$2.89M
SBUX icon
69
Starbucks
SBUX
$121B
$22.7M 0.38%
236,285
-3,816
-2% -$371K
PFE icon
70
Pfizer
PFE
$142B
$22.6M 0.38%
784,565
-49,274
-6% -$1.49M
VSH icon
71
Vishay Intertechnology
VSH
$5.18B
$22.3M 0.38%
930,292
-215,950
-19% -$5.01M
CCJ icon
72
Cameco
CCJ
$38.4B
$21.6M 0.36%
501,536
-8,463
-2% -$354K
CYTK icon
73
Cytokinetics
CYTK
$10.9B
$21.6M 0.36%
258,358
-971
-0.4% -$35.2K
CGNX icon
74
Cognex
CGNX
$10.4B
$21.6M 0.36%
516,506
-8,661
-2% -$333K
IBM icon
75
IBM
IBM
$209B
$21.4M 0.36%
131,097
+327
+0.3% +$49.4K

Similar funds

Pinnacle Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Pinnacle Associates held 851 positions worth $5.94B, up 10% from $5.38B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Pinnacle Associates's Q4 2023 filing shows 40 new, 303 increased, 396 reduced and 33 closed positions. Its largest new stake was Arm: 34,600 shares worth $2.6M. The largest sale was Seagen Inc. Common Stock, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Pinnacle Associates's largest Q4 2023 buy was Arm: 34,600 shares worth $2.6M.
  • Pinnacle Associates added most to Las Vegas Sands in Q4 2023, an estimated $6.05M increase.
  • Pinnacle Associates's biggest Q4 2023 reduction was Viavi Solutions, cutting an estimated $8.12M.
  • Pinnacle Associates fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $32.3M.
  • Pinnacle Associates's ten largest holdings make up 20% of its $5.94B portfolio in Q4 2023.
  • Pinnacle Associates opened 40 new positions and closed 33 in Q4 2023.
  • Pinnacle Associates's portfolio value rose 10% quarter-over-quarter to $5.94B.

Based on Pinnacle Associates's 13F filing for Q4 2023, filed 19 Jan 2024.